Ruoxin Li

Ruoxin Li is an accomplished professional in the field of data science and advanced analytics with extensive experience in the pharmaceutical and consulting industries. Since February 2019, Ruoxin has served as Senior Director at IQVIA, following a role as Director of Advanced Analytics for Immunology and Rare Disease at GSK from August 2016 to December 2018. Prior to GSK, Ruoxin held a position as Senior Analyst at Takeda Pharmaceuticals from April 2013 to June 2014 and worked at Bayser Consulting from November 2007 to March 2013, progressing from Consultant/Operation Research Analyst to Principal Consultant. Ruoxin holds a Master of Business Administration (MBA) from the University of California, Berkeley, earned in May 2018, and a Doctor of Philosophy (PhD) in Physics from Yale University, obtained in December 2007.